“Psilocybin is a proven treatment for depression.”
Randomized trials of psilocybin given with psychological support show short-term improvement in depression symptoms. The evidence base is still small, follow-up is limited, and participants often can tell whether they received a psychedelic, which can affect results. Research does not yet make it a routine, established treatment.
Psilocybin-assisted therapy is promising for depression, but calling it a proven treatment goes too far. Small controlled trials show short-term symptom improvement. We still need larger studies, longer follow-up and clearer evidence about who benefits and who may be harmed.
Mental health problems usually have more than one cause, and people can respond differently to the same treatment.
Safety note: Psilocybin can cause panic, confusion, increased blood pressure, paranoia or persistent psychosis. It is unsafe for some serious psychiatric conditions. Medication interactions are still being studied, so do not stop antidepressants or combine substances without clinical supervision.
Talk to a healthcare professional if: Do not self-treat depression with psilocybin. Discuss worsening depression, suicidal thoughts, psychiatric history and all medicines with a qualified clinician; use only a legal, regulated clinical program where available.
Promising trial results do not make unsupervised mushrooms equivalent to the screened drug, dose, psychological support and monitoring used in research.
Use established depression care now. If you are interested in psilocybin research, ask a clinician about legitimate trials or regulated programs and do not change prescribed medicines on your own.
Similar claims on Psychedelics (psilocybin, MDMA therapy)
Worth watching with cautious optimism, not hype: early results are genuinely encouraging for hard-to-treat conditions, but this is investigational medicine for professional settings, not a self-help shortcut.